Pinealon
Also known as: Peptídeo cerebral
Molecular Identifiers
Overview
Cerebral bioregulatory tripeptide developed by the Khavinson group. Modulates gene expression in brain tissue, with neuroprotective properties and circadian rhythm support. Used in short, repeated cycles.
EDR Glu-Asp-Arg Half-life
~2-4 hours
Administration Route
Subcutaneous or intramuscular
Category
Cognitive & Neuroprotective
Mechanism of Action
- Modulation of gene expression in brain tissues
- Neuroprotection against oxidative stress and neurotoxicity
- Support for circadian rhythm regulation
- Normalization of melatonin synthesis by the pineal gland
- Peptide bioregulatory effect on the central nervous system
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 5-10 mg per day subcutaneously or orally |
| Frequency | Once daily |
| Timing | Preferably in the evening |
| Duration | 10-30 days, cycled periodically |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Mild drowsiness
- Injection site pain (rare)
Presentations & Preparation
Vials of Pinealon found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 2 ml per vial
- Slowly inject the diluent against the vial wall
- Gently swirl until fully dissolved
- Never shake
- Also available in oral capsules
Storage
- Lyophilized: Refrigerated 2-8°C
- Reconstituted: Refrigerated 2-8°C (up to 30 days)
- Protect from direct light
- Do not freeze after reconstitution
Scientific Studies
Published studies on Pinealon.
Pinealon Increases Cell Viability by Suppression of Free Radical Levels and Activating Proliferative Processes
Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A
EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease
Khavinson V, Linkova N, Kozhevnikova E, Trofimova S
Related Peptides
Adamax
100-500 mcg via intranasal or subcutaneous · 1-2 times daily
Cerebrolysin
5-30 ml per injection · Once daily
Cortagen
5-10 mg per day via subcutaneous injection · Once daily
Dihexa
10-20 mg per subcutaneous injection or oral (research) · Once daily
DSIP
100-300 mcg per subcutaneous injection · Once daily
Epithalon
5-10 mg per injection · Once daily or every other day